Sepsis Diagnostics Market Key Drivers and Challenges 2022
The Global Sepsis Diagnostics Market was worth USD 370 million in 2016 and estimated to be growing at a CAGR of 8.8%, to reach USD 564.1 million by 2021. The increasing prevalence of the disease and its fatal effects has stimulated its growth.
Global Sepsis Diagnostics Market Overview:
The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However, factors like lack of standard protocols, lack of awareness and death or skilled staff are likely to hamper the growth of the market.
Global Sepsis Diagnostics Market Segmentation:
The Global Sepsis Diagnostics Market is segmented based on Pathogen, Product, Technology, Method and Usability.
Based on Pathogen – Bacterial and Fungal
Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents
Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry
Based on Method – Conventional and Automated
Based on Usability - Laboratory and Point-of-care testing
Avail Sample Market Brochure of the report @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/request-sample
Geographical Brief:
Based on the Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa.
North America is leading the market while Europe is at second place.
Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market.
Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Inquiry before buying @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Global Sepsis Diagnostics Market Overview:
The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However, factors like lack of standard protocols, lack of awareness and death or skilled staff are likely to hamper the growth of the market.
Global Sepsis Diagnostics Market Segmentation:
The Global Sepsis Diagnostics Market is segmented based on Pathogen, Product, Technology, Method and Usability.
Based on Pathogen – Bacterial and Fungal
Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents
Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry
Based on Method – Conventional and Automated
Based on Usability - Laboratory and Point-of-care testing
Avail Sample Market Brochure of the report @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/request-sample
Geographical Brief:
Based on the Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa.
North America is leading the market while Europe is at second place.
Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market.
Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Inquiry before buying @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/